Keyphrases
All-oral Regimen
13%
Ambient Ozone
13%
Amikacin
18%
Anaemia Status
13%
Black Residents
13%
Chronic Obstructive Pulmonary Disease
90%
Chronic Obstructive Pulmonary Disease Assessment Test
14%
Clofazimine
18%
Confidence Interval
24%
Current Smokers
15%
Disease Morbidity
29%
Eicosapentaenoic Acid
13%
Exacerbation Risk
21%
FEV1 Decline
13%
Food Insecurity
13%
Former Smokers
38%
Health Outcomes
17%
Health-related Quality of Life
13%
Imipenem
22%
Indoor Air Pollution
14%
Indoor Particulate Matter
13%
Linezolid
22%
Lung Disease
20%
Lung Function Decline
13%
Mouse Model
30%
Mycobacterium Abscessus
26%
Mycobacterium Avium Complex Pulmonary Disease
13%
Mycobacteroides Abscessus
28%
Neighborhood Deprivation
16%
Neighborhood Factors
13%
Omadacycline
41%
Omega-3
13%
Ozone Effect
13%
Patient-reported Health
13%
Patient-reported Symptoms
13%
Perceived Stress
27%
Phthalates
13%
Pollution Function
13%
Racial Disparities
13%
Racial Segregation
13%
Respiratory Morbidity
15%
Respiratory Outcomes
45%
Respiratory Symptoms
18%
Severe Exacerbations
17%
Smokers
13%
Specific Quality of Life
14%
SPIROMICS
27%
St. George's Respiratory Questionnaire
14%
Three-drug Regimen
13%
Three-level
13%
Medicine and Dentistry
8 Isoprostane
5%
Adverse Outcome
13%
Air Trapping
6%
Anemia
13%
Atmospheric Aerosol
27%
Biological Marker
15%
Bronchiectasis
5%
Chronic Obstructive Pulmonary Disease
100%
Computer Assisted Tomography
5%
Disease Assessment
6%
Docosahexaenoic Acid
12%
Dyspnea
10%
Emphysema
6%
Health Outcomes
21%
Icosapentaenoic Acid
13%
Lung
13%
Medical Research
11%
Mixed Model
8%
Mycobacterium Avium Complex
13%
Omega-3 Fatty Acid
13%
Oxidative Stress
17%
Particular Matter 2.5
5%
Perceived Stress Scale
12%
Quality of Life
32%
Racial Disparity
13%
Respiratory Physiology
9%
Silo-Filler's Disease
13%
Six Minute Walk Test
6%
Smoking
60%
Socioeconomic Status
15%
St. George Respiratory Questionnaire
8%
Symptom
23%
Thiobarbituric Acid Reactive Substance
5%
Thrombocyte Activation
17%
Thromboxane B2
5%
Pharmacology, Toxicology and Pharmaceutical Science
8 Isoprostane
5%
Amikacin
15%
Antibiotic Agent
5%
Biological Marker
17%
Bronchiectasis
7%
Chronic Obstructive Lung Disease
85%
Clofazimine
15%
Disease
21%
Disease Exacerbation
8%
Imipenem
17%
Linezolid
17%
Lung Disease
31%
Mixed Model
9%
Mouse Model
27%
Mycobacterium Avium Complex
13%
Nitrogen Dioxide
6%
Omadacycline
27%
Phthalic Acid
13%
Symptom
15%
TBARS
5%
Thromboxane B2
5%